In Vitro Efficacy Testing of TONS504 ‐Based Photodynamic Antimicrobial Chemotherapy ( TONS504 ‐ PACT ) Under a 405‐nm Light‐Emitting Diode Against Antimicrobial‐Resistant Bacteria Causing Canine Keratitis
Veterinary Ophthalmology · 2026
DOI: 10.1111/vop.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2026. Verfasst von Tomoya Furujo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Joint Graduate School of Veterinary Sciences, Tottori University, Tottori, Japan. Hauptthemen laut MEDLINE: Keratitis, Dog Diseases, Photosensitizing Agents, Photochemotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To evaluate the in vitro efficacy of photodynamic antimicrobial chemotherapy (PACT) using TONS504, a newly developed hydrophilic and cationic photosensitizer, under a blue light emitting diode (LED) against antimicrobial‐resistant bacteria isolated from dogs with keratitis.
Methods
Three bacterial strains (i.e., methicillin‐resistant Staphylococcus pseudintermedius , extended‐spectrum beta‐lactamase‐producing Escherichia coli , and Pseudomonas aeruginosa ), isolated from two dogs with keratitis, were used in this study after antimicrobial susceptibility tests. PACT using TONS504 (0.1–100 mg/L) was performed under a 405‐nm LED at 30 J/cm 2 (20 mW/cm 2 , 25 min) against bacterial suspensions (1.0 × 10 7–8 CFU). Bacterial strains that were unexposed, exposed to TONS504 only, or exposed to blue light only served as controls. Antimicrobial effects were assessed by calculating the survival fraction based on the assessment of colony‐forming units (CFU) on agar plates.
Results
Exposure to TONS504 or blue light only did not decrease the bacterial survival fraction against any of the strains. After TONS504‐PACT under blue light against S. pseudintermedius , no colonies were observed at any TONS504 concentration, resulting in an approximate reduction of 2.3 × 10 8 in the survival fraction. TONS504‐PACT under blue light against E. coli and P. aeruginosa at 10 mg/L of TONS504 showed the greatest reduction in survival fraction, and the reduction was substantially lower than those of the respective controls.
Conclusions
TONS504‐PACT under blue light exhibited satisfactory activity against antimicrobial‐resistant bacteria in vitro. Further research on the safety and clinical efficacy of TONS504‐PACT under blue light is required; however, it is a potential treatment for antimicrobial‐resistant bacterial keratitis in veterinary ophthalmology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Graduate School of Veterinary Sciences, Tottori University, Tottori, Japan.
- JS-Stage Inc., Okayama, Japan.
ORCID-Profile: Tomohiro Osaki
Zitieren
APA
Furujo, T., Harada, K., Ito, N., Sakata, I., & Osaki, T. (2026). In Vitro Efficacy Testing of TONS504 ‐Based Photodynamic Antimicrobial Chemotherapy ( TONS504 ‐ PACT ) Under a 405‐nm Light‐Emitting Diode Against Antimicrobial‐Resistant Bacteria Causing Canine Keratitis. Veterinary Ophthalmology. https://doi.org/10.1111/vop.70028
Vancouver
Furujo T, Harada K, Ito N, Sakata I, Osaki T. In Vitro Efficacy Testing of TONS504 ‐Based Photodynamic Antimicrobial Chemotherapy ( TONS504 ‐ PACT ) Under a 405‐nm Light‐Emitting Diode Against Antimicrobial‐Resistant Bacteria Causing Canine Keratitis. Veterinary Ophthalmology. 2026. doi:10.1111/vop.70028
BibTeX
@article{Furujo2026,
author = {Furujo, Tomoya and Harada, Kazuki and Ito, Norihiko and Sakata, Isao and Osaki, Tomohiro},
title = {In Vitro Efficacy Testing of TONS504 ‐Based Photodynamic Antimicrobial Chemotherapy ( TONS504 ‐ PACT ) Under a 405‐nm Light‐Emitting Diode Against Antimicrobial‐Resistant Bacteria Causing Canine Keratitis},
journal = {Veterinary Ophthalmology},
year = {2026},
doi = {10.1111/vop.70028}
}
EUVIMED